Core Viewpoint - The company Boji Pharmaceutical has received a drug registration certificate for its product, Compound Polyethylene Glycol Electrolyte Powder, from the National Medical Products Administration, indicating a significant regulatory milestone for the company [1] Group 1 - The product is intended for bowel cleansing preparation prior to endoscopic or radiological examinations and colon surgeries, highlighting its clinical application [1] - The registration certificate was issued to the company's wholly-owned subsidiary, Guangzhou Huasheng Pharmaceutical Co., Ltd., indicating the company's operational structure and focus on specialized subsidiaries [1]